Fermenta Biotech News
News
0
Ticker
506414.BO
ISIN
INE225B01021
Fermenta Biotech Eulerpool News
Fermenta Biotech Stock News
Fermenta Biotech is being monitored by journalists and investors worldwide. We gather the latest Fermenta Biotech news here.
Fermenta Biotech Stock Press Releases
Fermenta Biotech regularly publishes news on the company's website that are relevant for investors.
Fermenta Biotech News 2026
This page contains all current news, analysis and press releases for Fermenta Biotech stock (506414.BO, ISIN: INE225B01021). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Fermenta Biotech.
Fermenta Biotech Stock
Fermenta Biotech Fermenta Biotech Ltd is a pharmaceutical company headquartered in Thane, India, listed on the stock exchange on 4 January 1990. With a workforce of 550 employees, the firm operates primarily in the manufacturing and supply of Vitamin D3 and other bulk drugs. Its Chemicals and Bulk Drug segment produces enzymes and specialized technologies for the biopharmaceutical life cycle, serving industries such as pharmaceuticals, animal feed, and food fortification. Additionally, the company offers nutritional ingredients like fish oil-derived cholesterol and natural astaxanthin. The Property segment complements these operations by managing the renting and sale of real estate assets.